Late Mortality Persists Beyond Five Years in Children with Cancer
October 6, 2008 — Researchers affiliated with the Children’s Oncology Group have reported that children with cancer who survive five years still remain at risk and need continued observation. The details of this study appeared in an early online publication in the Journal of the National Cancer Institute on September 23, 2008.
Addition of Avastin® to Tarceva® Does Not Appear to Improve Survival in Patients with Advanced Non–Small Cell Lung Cancer
October 6, 2008 — According to the results of a Phase III clinical trial, treatment with Avastin® (bevacizumab) plus Tarceva® (erlotinib) did not result in better survival than treatment with Tarceva alone among patients with advanced non–small cell lung cancer (NSCLC) whose disease had progressed following platinum-based chemotherapy. These results were recently published in a press release by Genentech.
Possible Link between Hepatitis B Virus and Pancreatic Cancer
October 6, 2008 — Researchers from the M. D. Anderson Cancer Center in Texas have reported that exposure to the hepatitis B virus may be associated with the development of pancreatic cancer. The study was recently published in the October 1, 2008 issue of the Journal of Clinical Oncology.
Select news items provided by Reuters Health